Guerbet
GBT | PA
Overview
Corporate Details
- ISIN(s):
- FR0000032526 (+3 more)
- LEI:
- 969500WV1U1WQ059L135
- Country:
- France
- Address:
- 15 RUE DES VANESSES, 93420 VILLEPINTE
- Website:
- https://www.guerbet.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
At Guerbet, we build lasting relationships so that we enable people to live better. This is our Purpose. We place human cooperation at the heart of our relationships and actions. We are a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media, we are a team of over 2,600 people globally, continuously innovating with 10% of revenue dedicated to Research & Development across four centers in France, Israel and the United States.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-13 17:45 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 158.8 KB | |
2025-07-25 17:45 |
Regulatory News Service
GUERBET : Descriptif du programme de rachat d’actions autorisé par l’Assemblée …
|
French | 170.5 KB | |
2025-07-09 17:45 |
Regulatory News Service
GUERBET : Bilan semestriel du contrat de liquidité
|
French | 116.1 KB | |
2025-07-08 17:30 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 99.1 KB | |
2025-06-18 17:30 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 98.5 KB | |
2025-05-26 08:42 |
Post-Annual General Meeting Information
Guerbet : Evolution de la composition du Conseil d'administration de Guerbet.
|
French | 250.9 KB | |
2025-05-26 08:42 |
Board/Management Information
Guerbet : Changes in the composition of the Guerbet board of directors.
|
English | 164.7 KB | |
2025-05-16 17:30 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.3 KB | |
2025-04-24 17:45 |
Earnings Release
Guerbet: Q1 2025 revenue
|
English | 473.1 KB | |
2025-04-24 17:45 |
Earnings Release
GUERBET: Chiffre d’affaires du 1er trimestre 2025
|
French | 478.4 KB | |
2025-04-11 17:45 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 96.3 KB | |
2025-04-03 15:20 |
Registration Form
GUERBET : Mise à disposition du Document d’enregistrement universel 2024
|
French | 147.4 KB | |
2025-04-03 12:24 |
Annual Report (ESEF)
GUERBET - DEU 2024
|
French | 31.0 MB | |
2025-03-26 17:45 |
Investor Presentation
GUERBET : Résultats annuels 2024.
|
French | 298.5 KB | |
2025-03-26 17:45 |
Earnings Release
GUERBET : 2024 full-year results.
|
English | 241.1 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2024-08-19 | N/A | Other | Buy | 142 | 4,989.31 EUR |
2024-08-15 | N/A | Other | Buy | 195 | 6,678.75 EUR |
2024-08-12 | N/A | Other | Buy | 1,000 | 34,350.00 EUR |
2024-04-18 | N/A | Other | Sell | 550 | 17,699.00 EUR |
2023-11-30 | N/A | Other | Sell | 700 | 12,684.00 EUR |
2023-11-03 | N/A | Other | Buy | 1 | 17.92 EUR |
2023-10-30 | N/A | Other | Buy | 1,000 | 17,000.00 EUR |
2023-10-25 | N/A | Other | Buy | 1,000 | 16,800.00 EUR |
2023-10-24 | N/A | Other | Buy | 1,000 | 16,460.90 EUR |
2023-05-04 | N/A | Other | Buy | 300 | 4,938.00 EUR |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Antibiotice S.A. | Romania | ATB | |
![]() |
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
![]() |
Asarina Pharma AB | Sweden | ASAP | |
ASKA Pharmaceutical Holdings CO., Ltd. | Japan | 4886 | ||
![]() |
Astellas Pharma Inc. | Japan | 4503 | |
![]() |
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
![]() |
Biofarm S.A. | Romania | BIO | |
![]() |
Biogened Spolka Akcyjna | Poland | BGD |